


@article{Scuccimarri2020HydroxychloroquinePandemic,
    author = {Scuccimarri, Rosie and Sutton, Evelyn and Fitzcharles, Mary-Ann},
    title = {Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic.},
    journal = {J Rheumatol},
    issn = {},
    year = {2020},
    volume = {},
    number = {},
    pages = {},
    doi = {10.3899/jrheum.200369}
    citedbycount = {0},
    abstract = {Two antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ), have been trusted treatments for a range of rheumatic diseases over the past seventy years [1]. These agents have attracted intense media attention in the past few weeks with suggestions that this category of drugs may have potential in the management of coronavirus (SARS-CoV2) associated disease called COVID-19 [2, 3].},
    keywords = {}
}
